This brand name is authorized in Finland, Croatia, Ireland, Poland, Romania, United Kingdom
The drug ITULAZAX contains one active pharmaceutical ingredient (API):
| 1 Standardized allergen extract from Betula verrucosa pollen |
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ITULAZAX 12SQ-BET Oral lyophilisate | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V01AA05 | Tree pollen | V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 081344, 462544 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-926972641 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100409105 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66619001, W66619002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
